ORBIMED ADVISORS LLC Mereo BioPharma Group plc Transaction History

ORBIMED ADVISORS LLC portfolio value:

$9.13M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

-23.12%
quarter

Mereo BioPharma Group plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +9.21% 894.1K shares -1.74M $0.86 10.60M
Q2 2022 share Decrease -43.75% -7.55M shares -8.45M $1.12 9.71M
Q1 2022 share 0.00% 0 shares -8.28M $1.12 17.26M
Q4 2021 share 0.00% 0 shares -14.15M $1.61 17.26M
Q3 2021 share 0.00% 0 shares -12.94M $2.42 17.26M
Q2 2021 share Increase 0.00% 1 shares -3.45M $3.17 17.26M
Q1 2021 share Increase +24.96% 3.44M shares 8.72M $3.37 17.26M
Q4 2020 share Increase 0.00% 13.81M shares 49.46M $3.58 13.81M